KCNA3 and Anxiety: Because dopaminergic signaling may be involved in modulating anxiety-like behaviors (Sullivan et al., 2014), we explored whether there were differences in basal DA or MPH treatment effects on DA signaling in WT vs. Kv1.3−/− mice.